Literature DB >> 11779595

Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency.

Babak Imani1, Marinus J C Eijkemans, Gerry H Faessen, Philippe Bouchard, Linda C Giudice, Bart C J M Fauser.   

Abstract

OBJECTIVE: To predict the FSH response (threshold) dose in normogonadotropic, anovulatory infertile women undergoing gonadotropin induction of ovulation.
DESIGN: Prospective longitudinal clinical study.
SETTING: Specialist academic fertility unit. PATIENT(S): Normogonadotropic, oligoamenorrheic, infertile women who were resistant to clomiphene citrate or in whom clomiphene citrate therapy had failed. INTERVENTION(S): Daily exogenous FSH administration in a low-dose, step-up regimen. MAIN OUTCOME MEASURE(S): The FSH dose on the day of ovarian response (follicle growth > 10 mm in diameter). RESULT(S): Multivariate analysis was used to devise the following equation to predict the individual FSH response dose (75 to >187 IU/d) before initiation of therapy: [4 body mass index (in kg/m(2))] + [32 clomiphene citrate resistance (yes = 1 or no = 0)] + [7 initial free insulin-like growth factor-I (in ng/mL)] + [6 initial serum FSH level (in IU/L)] - 51. The SE of the predicted dose is 35 IU. CONCLUSION(S): The individual FSH response dose for gonadotropin induction of ovulation in anovulatory infertile women can be predicted on the basis of initial screening characteristics. The prediction model developed in this study may increase the safety and efficiency of low-dose gonadotropin protocols (step-up and step-down) by correctly determining the appropriate starting dose for a given patient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779595     DOI: 10.1016/s0015-0282(01)02928-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Anovulation and ovulation induction.

Authors:  I Katsikis; M Kita; A Karkanaki; N Prapas; D Panidis
Journal:  Hippokratia       Date:  2006-07       Impact factor: 0.471

Review 2.  Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment.

Authors:  Anwen Gorry; Davinia M White; Stephen Franks
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

3.  Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study.

Authors:  Yan Sheng; Guangxiu Lu; Jiayin Liu; Xiaoyan Liang; Yanping Ma; Xuehong Zhang; Songying Zhang; Yingpu Sun; Yun Sun; Wenfeng Chen; Wenhui Fang; Zijiang Chen
Journal:  J Assist Reprod Genet       Date:  2016-11-05       Impact factor: 3.412

4.  Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins.

Authors:  A Nyboe Andersen; A H Balen; P Platteau; G Pettersson; J-C Arce
Journal:  Hum Reprod       Date:  2010-06-03       Impact factor: 6.918

Review 5.  Contemporary pharmacological manipulation in assisted reproduction.

Authors:  Judith A F Huirne; Cornelis B Lambalk; Andre C D van Loenen; Roel Schats; Peter G A Hompes; Bart C J M Fauser; Nick S Macklon
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  A Preliminary Report of A Low-Dose Step-Up Regimen of Recombinant Human FSH for Young Women Undergoing Ovulation Induction with IUI.

Authors:  Hsin-Fen Lu; Fu-Shiang Peng; Shee-Uan Chen; Bao-Chu Chiu; Szu-Hsing Yeh; Sheng-Mou Hsiao
Journal:  Int J Fertil Steril       Date:  2015-12-23

Review 7.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

8.  Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate.

Authors:  Anders Nyboe Andersen; Adam Balen; Peter Platteau; Paul Devroey; Lisbeth Helmgaard; Joan-Carles Arce
Journal:  Hum Reprod       Date:  2008-03-26       Impact factor: 6.918

9.  Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction.

Authors:  Gamal I Serour; Mohamed Aboulghar; Awatef Al Bahar; Jean-Noel Hugues; Khaled Esmat
Journal:  Reprod Biol Endocrinol       Date:  2014-06-18       Impact factor: 5.211

10.  Effect of Female Body Mass Index on Oocyte Quantity in Fertility Treatments (IVF): Treatment Cycle Number Is a Possible Effect Modifier. A Register-Based Cohort Study.

Authors:  Mette Wulf Christensen; Hans Jakob Ingerslev; Birte Degn; Ulrik Schiøler Kesmodel
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.